Xihua Pharma

Xihua Pharma, founded in 2021, operates as a specialized subsidiary of Shanghai Xihua Scientific, focusing on comprehensive drug development and manufacturing services. The company provides an integrated Chemistry, Manufacturing, and Controls (CMC) platform designed to support pharmaceutical R&D from preclinical stages through to commercial manufacturing. Their technical capabilities encompass API process R&D, formulation development, and regulatory affairs, catering to both small and large molecules, as well as advanced gene and cell therapy products. Meet Xihua Pharma's team to understand the expertise driving these specialized pharmaceutical solutions.

Operating with a workforce of 500-1,000 employees, Xihua Pharma maintains a strategic presence in Shanghai, China. The organization leverages its integrated platform to offer one-stop solutions that streamline the drug development lifecycle. By focusing on customized R&D workflows, the company aims to accelerate the transition of therapeutic candidates from laboratory settings to clinical and commercial production environments. Their operational model is built to address the complex requirements of modern drug manufacturing, ensuring compliance and efficiency across all development phases.

The company serves as a critical partner in the healthcare sector, empowering pharmaceutical innovation through its robust technical infrastructure. By providing end-to-end support, Xihua Pharma facilitates the advancement of diverse therapeutic modalities. Their commitment to high-quality manufacturing standards and regulatory excellence positions them as a key player in the global pharmaceutical services market, dedicated to delivering innovative solutions that ultimately benefit patient outcomes through rigorous scientific development and manufacturing precision.